Influence of incidental dural tears and their primary microendoscopic repairs on surgical outcomes in patients undergoing microendoscopic lumbar surgery.


Journal

The spine journal : official journal of the North American Spine Society
ISSN: 1878-1632
Titre abrégé: Spine J
Pays: United States
ID NLM: 101130732

Informations de publication

Date de publication:
09 2019
Historique:
received: 28 12 2018
revised: 16 04 2019
accepted: 17 04 2019
pubmed: 23 4 2019
medline: 2 5 2020
entrez: 23 4 2019
Statut: ppublish

Résumé

Dural tear represents a common complication of microendoscopic spine surgery that may lead to postoperative sequelae including insufficient decompression, cerebrospinal fluid fistula, intracranial hypotension, and subdural/intraparenchymal bleeding. The gold standard to manage intraoperative dural tears is primary repair. However, the downside of conversion to open surgery can be detrimental. Therefore, understanding the most appropriate strategy for microendoscopic dural repair and its impact on postoperative outcomes is of importance. The purpose of this study was to investigate the incidence of dural tears in patients undergoing microendoscopic lumbar surgery and to elucidate their influence on surgical outcomes whenever proper repair is accomplished microendoscopically without conversion to open surgery. A retrospective multicenter cohort study of prospectively enrolled patients using a propensity-matched analysis. A total of 922 consecutive patients underwent microendoscopic surgery of the lumbar spine between February and December 2012 in the three institutions belonging to our study group. Outcome measures included the Numeric Rating Scale for back and leg pain, Oswestry Disability Index, Japanese Orthopaedic Association score, Short Form-36, and a patients' satisfaction scale. All incidental dural tears were repaired by microendoscopic suture of the dura mater from inside to outside using double-arm needles and/or by fibrin glue coverage without being converted to open surgery. Surgical outcomes were compared between patients with and without dural tears using a propensity-matched analysis. Microendoscopic discectomy for lumbar disc herniation was performed on 474 patients, whereas microendoscopic laminectomy and posterior lumbar interbody fusion for lumbar canal stenosis were performed on 271 and 177 patients, respectively. Dural tears occurred in 49 (5.3%) patients. Of these, 23 (2.5%) patients required suture repair, whereas the rest received a fibrin patch for a pinhole tear, all of which were successfully performed under microendoscopy. Six hundred (65.1%) patients responded pre- and postoperatively to the questionnaire. Of them, the responses of 38 patients with dural tears were compared with those of 38 matched patients. No significant differences in any outcome measures were observed between the two groups. In conclusion, all dural tears in our cases were managed without conversion to open surgery and did not influence surgical outcomes.

Sections du résumé

BACKGROUND CONTEXT
Dural tear represents a common complication of microendoscopic spine surgery that may lead to postoperative sequelae including insufficient decompression, cerebrospinal fluid fistula, intracranial hypotension, and subdural/intraparenchymal bleeding. The gold standard to manage intraoperative dural tears is primary repair. However, the downside of conversion to open surgery can be detrimental. Therefore, understanding the most appropriate strategy for microendoscopic dural repair and its impact on postoperative outcomes is of importance.
PURPOSE
The purpose of this study was to investigate the incidence of dural tears in patients undergoing microendoscopic lumbar surgery and to elucidate their influence on surgical outcomes whenever proper repair is accomplished microendoscopically without conversion to open surgery.
STUDY DESIGN/SETTING
A retrospective multicenter cohort study of prospectively enrolled patients using a propensity-matched analysis.
PATIENT SAMPLE
A total of 922 consecutive patients underwent microendoscopic surgery of the lumbar spine between February and December 2012 in the three institutions belonging to our study group.
OUTCOME MEASURES
Outcome measures included the Numeric Rating Scale for back and leg pain, Oswestry Disability Index, Japanese Orthopaedic Association score, Short Form-36, and a patients' satisfaction scale.
METHODS
All incidental dural tears were repaired by microendoscopic suture of the dura mater from inside to outside using double-arm needles and/or by fibrin glue coverage without being converted to open surgery. Surgical outcomes were compared between patients with and without dural tears using a propensity-matched analysis.
RESULTS
Microendoscopic discectomy for lumbar disc herniation was performed on 474 patients, whereas microendoscopic laminectomy and posterior lumbar interbody fusion for lumbar canal stenosis were performed on 271 and 177 patients, respectively. Dural tears occurred in 49 (5.3%) patients. Of these, 23 (2.5%) patients required suture repair, whereas the rest received a fibrin patch for a pinhole tear, all of which were successfully performed under microendoscopy. Six hundred (65.1%) patients responded pre- and postoperatively to the questionnaire. Of them, the responses of 38 patients with dural tears were compared with those of 38 matched patients. No significant differences in any outcome measures were observed between the two groups.
CONCLUSIONS
In conclusion, all dural tears in our cases were managed without conversion to open surgery and did not influence surgical outcomes.

Identifiants

pubmed: 31009767
pii: S1529-9430(19)30154-8
doi: 10.1016/j.spinee.2019.04.015
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1559-1565

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Kazuhito Soma (K)

Department of Orthopaedic Surgery, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan; Department of Orthopaedic Surgery, Inanami Spine and Joint Hospital, 3-17-5 Higashishinagawa Shinagawa-ku, Tokyo, 140-0002, Japan.

So Kato (S)

Department of Orthopaedic Surgery, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Hiroyuki Oka (H)

Department of Medical Research and Management for Musculoskeletal Pain, 22nd Century Medical & Research Center, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Ko Matsudaira (K)

Department of Medical Research and Management for Musculoskeletal Pain, 22nd Century Medical & Research Center, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Masayoshi Fukushima (M)

Department of Orthopaedic Surgery, Inanami Spine and Joint Hospital, 3-17-5 Higashishinagawa Shinagawa-ku, Tokyo, 140-0002, Japan.

Masahito Oshina (M)

Department of Orthopaedic Surgery, Inanami Spine and Joint Hospital, 3-17-5 Higashishinagawa Shinagawa-ku, Tokyo, 140-0002, Japan.

Hisashi Koga (H)

Department of Orthopaedic Surgery, Iwai Orthopaedic Medical Hospital, 8-17-2 Minamikoiwa Edogawa-ku, Tokyo, 133-0056, Japan.

Yuichi Takano (Y)

Department of Orthopaedic Surgery, Iwai Orthopaedic Medical Hospital, 8-17-2 Minamikoiwa Edogawa-ku, Tokyo, 133-0056, Japan.

Hiroki Iwai (H)

Department of Orthopaedic Surgery, Inanami Spine and Joint Hospital, 3-17-5 Higashishinagawa Shinagawa-ku, Tokyo, 140-0002, Japan.

Mario Ganau (M)

Department of Neurosurgery, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 9DU, United Kingdom.

Sakae Tanaka (S)

Department of Orthopaedic Surgery, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Hirohiko Inanami (H)

Department of Orthopaedic Surgery, Inanami Spine and Joint Hospital, 3-17-5 Higashishinagawa Shinagawa-ku, Tokyo, 140-0002, Japan.

Yasushi Oshima (Y)

Department of Orthopaedic Surgery, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. Electronic address: yoo-tky@umin.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH